DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]

Pharvaris has secured approximately $175 million through a public offering [...]

Selection of CRO marks key milestone in advancing CS1 as [...]

Renowned neuromuscular clinician and researcher to shape care strategies and [...]

As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

Clinical trial platform’s AI and navigator-led model bridges gap in [...]